SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000920465-20-000123
Filing Date
2020-07-29
Accepted
2020-07-29 17:24:15
Documents
1
Period of Report
2020-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159605762197505.html 4  
1 FORM 4 wf-form4_159605762197505.xml 4 5221
  Complete submission text file 0000920465-20-000123.txt   6836
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Reporting) CIK: 0000920465 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35837 | Film No.: 201058048
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Issuer) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations